These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14710231)

  • 21. [Relationship between the expression of vascular endothelial growth factor, fms-like tyrosine kinase-1 and biological behavior in gastric carcinoma].
    Wang YY; Ye ZY; Zhao ZS; Tao HQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):269-73. PubMed ID: 17633783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis.
    Lim JJ; Kang S; Lee MR; Pai HK; Yoon HJ; Lee JI; Hong SP; Lim CY
    J Oral Pathol Med; 2003 Oct; 32(9):552-61. PubMed ID: 12969230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.
    Maehara Y; Tomoda M; Hasuda S; Kabashima A; Tokunaga E; Kakeji Y; Sugimachi K
    Br J Cancer; 1999 Mar; 79(7-8):1255-61. PubMed ID: 10098768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
    Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
    Boku N; Chin K; Hosokawa K; Ohtsu A; Tajiri H; Yoshida S; Yamao T; Kondo H; Shirao K; Shimada Y; Saito D; Hasebe T; Mukai K; Seki S; Saito H; Johnston PG
    Clin Cancer Res; 1998 Jun; 4(6):1469-74. PubMed ID: 9626464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
    Tsujitani S; Saito H; Maeta Y; Yamaguchi K; Tatebe S; Kondo A; Kaibara N
    Anticancer Res; 2004; 24(3b):1853-9. PubMed ID: 15274366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater.
    Chen L; Tao SF; Zheng YX
    Hepatogastroenterology; 2006; 53(67):45-50. PubMed ID: 16506374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
    Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.
    Joo YE; Sohn YH; Joo SY; Lee WS; Min SW; Park CH; Rew JS; Choi SK; Park CS; Kim YJ; Kim SJ
    Korean J Intern Med; 2002 Dec; 17(4):211-9. PubMed ID: 12647634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.
    Choi JH; Ahn MJ; Park CK; Han HX; Kwon SJ; Lee YY; Kim IS
    APMIS; 2006 Sep; 114(9):619-25. PubMed ID: 16948814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
    Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
    Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
    World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
    Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P53 and vascular endothelial growth factor expressions are two important indices for prognosis in gastric carcinoma.
    Guo R; Li Q; Meng L; Zhang Y; Gu C
    West Indian Med J; 2008 Jan; 57(1):2-6. PubMed ID: 19565930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic significance of nuclear factor-κB and vascular endothelial growth factor expression in advanced gastric cancer patients.
    Park KW; Kim SJ; Oh SY
    Oncol Res Treat; 2014; 37(4):183-90. PubMed ID: 24732642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of vascular endothelial growth factor (VEGF) and p53 in breast lesions.
    Noranizah W; Siti-Aishah MA; Munirah MA; Norazlin MH; Rohaizak M; Naqiyah I; Sharifah NA; Das S
    Clin Ter; 2010; 161(2):129-37. PubMed ID: 20499026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.
    Cascinu S; Graziano F; Catalano V; Staccioli MP; Rossi MC; Baldelli AM; Barni S; Brenna A; Secondino S; Muretto P; Catalano G
    Br J Cancer; 2002 Mar; 86(5):744-9. PubMed ID: 11875737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.